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Relapse 
• intermittently 
or permanently 
 
Background 
• Little is known about treatment adherence behaviours amongst 
HIV patients on second and third-line antiretroviral therapy 
(ART) who may have unique experiences associated with 
reaching ‘the end’ of their treatment options.  
• Understanding these behaviours is important for ensuring 
tailored support is available to patients after regimen switches in 
order to address previously experienced adherence barriers, and 
prolong the effectiveness of treatment.  
Aim 
• We explored influences on adherence to second- and third-line 
ART regimens among people living with HIV (PLHIV) enrolled in 
HIV programmes supported by Médecins sans Frontières in 
Kenya, Malawi and Mozambique. 
Results 
Contemplation and preparation: In all sites, patients’ 
engagement with second and third-line ART was often shaped 
by experiencing life-threatening illnesses prior to switching 
regimens and being given “a final chance at life”. These events, 
alongside viral load and CD4 results, could catalyze change in 
patients’ attitudes to pill-taking and feelings of responsibility for 
managing their disease after regimen change.  
 
 
 
 
 
 
Action: These feelings of responsibility often prompted lifestyle 
changes such as giving up drinking, changing jobs that could 
interfere with treatment and reducing sexual encounters. Other 
patients reported psychosocial transformations and overcoming 
community stigma, disclosing their HIV status to others or being 
driven by a desire to stay alive to bring up their children. 
 
 
 
 
Transformations were often influenced by health workers’ 
advice. Counselling approaches were found to support patients 
to change adherence behavior, especially in Kenya. However in 
many cases treatment messages detracted from patients linking 
treatment failure to their ART adherence: 
 
 
 
 
 
Maintenance: some participants were able to maintain 
renewed commitment to second or third line ART. 
 
 
 
 
Relapse: However others risked relapsing given the persistence 
of multiple and interrelated social, economic and health 
systems challenges that had previously undermined their 
adherence. Increased side effects and greater pill burden 
associated with second and third-line regimens  compounded 
patients’ adherence challenges. 
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Methods  
• Repeated in-depth interviews (IDI) with 43 PLHIV on second- or 
third-line ART and 15 health workers across the 3 sites. 
• Participants purposively sampled from second and third-line 
patients receiving their current regimen for at least 6 months, 
and ensuring diversity across age, sex, virological outcomes and 
antiretroviral regimen type (table 1). 
 
 
 
 
 
 
 
 
 
1 <1000 cps/ml; ~12 months before IDI and at most recent VL test; 2 ≥ 1000 cps ~12 months before IDI 
• Observations in clinic activities and group education sessions.  
• Interviews  audio-recorded, transcribed, translated into English.  
• Data were coded inductively and analysed thematically. 
 
 
 
 
 
 
 
 
 
Conclusion 
• While well-established barriers to adherence remain for 
many patients after regimen change, others experienced a 
resurgence of hope as they overcame debilitating illness 
associated with prior treatment failure. Although this can 
initially encourage renewed efforts to adhere, the effects 
may wane over time.  
• Correct health messages on treatment failure alongside 
regular, patient-centered counseling or peer-led mentoring 
interventions may help promote and sustain these life 
transformations and support adherence, thereby prolonging 
the life-span of second and third-line regimens.  
 
Settings 
• Homa Bay (Kenya) and Chiradzulu (Malawi): rural, most 
participants engaged in subsistence farming/fishing, petty trade. 
• Maputo (Mozambique): urban, most participants engaged in 
formal employment. 
• HIV treatment and care is provided through decentralised health 
centres in Malawi, and  in district or referral hospitals in all sites.                                                                           
“My CD4 decreased and viral load went up to 2000 copies. So that's when they 
called my husband, they said `it’s better you talk to your wife because your wife 
is going to die '. And I was about to die. So then, in the hospital, my husband 
talked to me, I swore right there 'never again'. From that day, I was going to 
start taking the pills. And I started taking them normally, no problem.” [Woman, 
recently switched to 3rd line ART, Mozambique] 
 
“I felt a little embarrassed…I had already been told ‘eish you must not drink, you 
had better to control your time schedule to take pill, you must not have sex 
without using a condom, you must not sleep after the normal sleeping time'. 
But…some of the things, I did not keep them. So it culminated with this result 
(treatment failure).”  [Man, recently switched to 3rd-line ART, Mozambique] 
 
“They changed me to second line, when I took them I was having pains around 
the heart and I didn’t adhere to them as well….they had to put me on third 
line.  The only challenge at home now is food because if I take the medication 
without food I have complications. Food is always crucial for taking medication.” 
[Woman, recently switched to 3rd line ART, Malawi] 
 
Fig. 1: Study settings and HIV clinics in the 3 sites (from left to right: Homa Bay, Chiradzulu and Maputo) 
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Conceptual framework 
We applied the stages of change model (transtheoretical model 
[1]) to consider the psychological processes underlying PLHIVs 
adherence to new  ART regimens following treatment failure of 
first and/or second-line regimens, and the role of social, economic 
and health system influences in promoting or undermining this 
process (Figure 2). 
 
 ART adherence prior to 
treatment failure 
ART adherence following treatment failure 
Fig. 2: Process underlying ART adherence according to the stages of change model 
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“I had to organize my duties and my responsibilities in accordance to my time of 
taking drugs. I was an ardent fisherman, but nowadays I am an ardent gardener” 
[Man, on 2nd line ART with undetectable VL, Kenya] 
“You are coming from far away, when they started giving you 2 months (ART 
refill)…was that a short length of time to come back to the clinic? I am very 
flexible even if am given one day (ART refill) I will still be flexible because my life is 
more important.” [Woman, on 2nd line ART with undetectable VL, Kenya] 
Group   Kenya Malawi Mozambique  Total 
PLHIV 
No virological failure1 on 2nd line 5 4 4 13 
Virological failure2on 2nd line => no change, or switch 
to simplified/optimized 2nd line 
6 4 5 15 
Virological failure2 on 2nd line => switched to 3rd line 5 5 5 15 
Female 10 7 8 25 
Male 6 6 6 18 
Health 
Workers 
Clinical staff 2 4 2 8 
Counsellors and support staff 3 1 3 7 
TOTAL   21 18 19 58 
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Influences: i. social and community level (e.g. stigma, family /partner treatment support ); ii. economic level  
(e.g. employment/mobility conflicting with care and treatment schedules,  food availability); iii. health 
systems level (e.g. relations with health workers, ART messaging, side effects experienced) 
Table 1: participants across sites 
